Novo Nordisk A/S (NVO) Stock: AWS AI Partnership Targets Faster Drug Discovery

TLDR Novo Nordisk names AWS its preferred cloud and strategic AI partner worldwide. Novo and AWS open a London innovation hub focused on faster drug discovery. AWS tools will support drug targeting, therapy design, and clinical data work. More than 25,000 Novo employees have already used tools from the partnership. NVO stock traded at $47.26, [...]

The post Novo Nordisk A/S (NVO) Stock: AWS AI Partnership Targets Faster Drug Discovery appeared first on Blockonomi.